Ranbaxy launches acne drug in US

Mon Nov 26, 2012 1:44pm IST

Related Topics

Stocks

   

REUTERS - Ranbaxy Laboratories Ltd (RANB.NS), India's top drugmaker by sales, said it has launched Absorica, a drug used to treat recalcitrant acne, in the United States.

The drug is in-licensed from Cipher Pharmaceuticals Inc (DND.TO), said Ranbaxy, controlled by Japan's Daiichi Sankyo Co (4568.T), on Monday. (Reporting by Kaustubh Kulkarni in Mumbai)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Everest Tragedy

Everest Tragedy

Search ends for missing on Everest, some Sherpas call for shutdown.  Full Article 

Ukraine Crisis

Ukraine Crisis

Deadly gun attack in eastern Ukraine shakes fragile Geneva accord.  Full Article 

Hamilton Wins

Hamilton Wins

Lewis Hamilton wins Chinese GP in Mercedes one-two.  Full Article 

Monte Carlo Masters

Monte Carlo Masters

Wawrinka beats Federer to win Monte Carlo Masters.  Full Article 

Happy Easter

Happy Easter

Pope presides at Vatican Mass leading Catholics into Easter.  Full Article 

Box Office

Box Office

'Captain America' soars again, tops 'Rio 2' to win U.S. box office.  Full Article 

Bollywood

Bollywood

Movie Review: 2 States.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage